The role of idiotype vaccines in the treatment of human B-cell malignancies
/in International Publications, Malignant Lymphoma /von 2004-04-01 / Expert Rev Vaccines 2004 Apr;3(2):163-70Dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8Immunotherapy for lymphomas
/in International Publications, Malignant Lymphoma /von 2003-06-01 / Int. J. Hematol. 2003 Jun;77(5):444-55Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma
/in International Publications, Malignant Lymphoma /von 2002-04-01 / Haematologica 2002 Apr;87(4):400-7Enhancement of hyperthermia-induced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2002-02-22 / J. Biol. Chem. 2002 May;277(21):18986-93Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2001-01-01 / Cancer Invest. 2001;19(8):791-8Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia
/in Hyperthermia, International Publications, Malignant Lymphoma /von 1999-11-01 / Int J Hyperthermia 1999 Nov-Dec;15(6):475-86Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology
/in Hyperthermia, International Publications, Malignant Lymphoma /von 1996-01-01 / Int J Hyperthermia 1996 Jan-Feb;12(1):3-20
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de